大型肠道手术患者的贫血症——患病率和当前实践：公立和私立机构的经验。
Anaemia in patients undergoing major bowel surgery - Prevalence and current practice: A public and private institution experience.
机构信息
School of Pharmacy, The 1974University of Queensland, Woolloongabba, Australia.
Mater Pharmacy, Mater Health, Brisbane, Australia.
出版信息
J Perioper Pract. 2021 Jun;31(6):215-222. doi: 10.1177/1750458920934321. Epub 2020 Jul 8.
AIM
The study aimed to compare the frequency and alignment of preoperative anaemia screening and treatment with Australian guidelines in elective bowel surgery and determine the impact on clinical outcomes.
METHODS
We performed a retrospective observational study, with an audit of 559 adult patients who underwent major elective bowel surgery in an Australian metropolitan hospital, January 2016-December 2018. Outcome measures included rate of anaemia, guideline compliance, hospital length of stay, and transfusion rate.
RESULTS
Preoperative anaemia assessment occurred in 82.6% of patients. However, only 5.2% received recommended biochemical tests at least one week before surgery. Only 25.2% of anaemic patients received preoperative treatment; they experienced a longer hospital length of stay (9.93 days versus 7.88 days, p < 0.001) and an increased rate of transfusion (OR: 3.186, p < 0.05).
CONCLUSION
The gaps between current preoperative anaemia screening, management and national guidelines may place patients at higher risk of poor surgical outcome.
目的
本研究旨在比较澳大利亚指南指导下择期肠手术的术前贫血筛查和治疗频率及一致性，并确定其对临床结局的影响。
方法
我们进行了一项回顾性观察性研究，对 2016 年 1 月至 2018 年 12 月在澳大利亚大都市医院接受大型择期肠手术的 559 例成年患者进行了审核。主要观察指标包括贫血发生率、指南依从性、住院时间和输血率。
结果
82.6%的患者接受了术前贫血评估。然而，只有 5.2%的患者在术前至少一周接受了推荐的生化检查。仅 25.2%的贫血患者接受了术前治疗，其住院时间更长（9.93 天 vs. 7.88 天，p<0.001），输血率更高（OR：3.186，p<0.05）。
结论
当前的术前贫血筛查、管理与国家指南之间存在差距，可能使患者面临更差的手术结局风险。
Zotero 插件